RBC Capital Downgrades Quest Diagnostics (DGX) to Sector Perform
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $244.39 +1.28%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital downgraded Quest Diagnostics (NYSE: DGX) from Outperform to Sector Perform. PT lowered from $67 to $61.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.36 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Super Retail Group Ltd. (SUL:AU) to Sector Perform
- DZ Bank Downgrades Frontline Ltd. (FRO) to Sell
- Morgan Stanley Downgrades oOh!media (OML:AU) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
